State of New Jersey Common Pension Fund D’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,827
Closed -$643K 1553
2025
Q4
$643K Buy
+29,827
New +$579K ﹤0.01% 1430
2019
Q3
Sell
-12,455
Closed -$36K 1600
2019
Q2
$36K Sell
12,455
-1,561
-11% -$2.68K ﹤0.01% 918
2019
Q1
$20K Hold
14,016
﹤0.01% 906
2018
Q4
$36K Hold
14,016
﹤0.01% 911
2018
Q3
$62K Sell
14,016
-28,074
-67% -$152K ﹤0.01% 922
2018
Q2
$258K Hold
42,090
﹤0.01% 936
2018
Q1
$307K Hold
42,090
﹤0.01% 917
2017
Q4
$345K Hold
42,090
﹤0.01% 905
2017
Q3
$442K Hold
42,090
﹤0.01% 903
2017
Q2
$464K Buy
42,090
+9,175
+28% +$92.1K ﹤0.01% 894
2017
Q1
$319K Hold
32,915
﹤0.01% 902
2016
Q4
$342K Hold
32,915
﹤0.01% 895
2016
Q3
$408K Hold
32,915
﹤0.01% 884
2016
Q2
$354K Buy
32,915
+12,695
+63% +$135K ﹤0.01% 900
2016
Q1
$223K Sell
20,220
-4,852
-19% -$48.2K ﹤0.01% 927
2015
Q4
$306K Buy
+25,072
New +$391K ﹤0.01% 939

Other funds holding AVDL

State of New Jersey Common Pension Fund D's AVDL Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 29,827 shares — an estimated $643K sold.

State of New Jersey Common Pension Fund D first reported a position in AVDL in Q4 2015 and held it in 16 quarters. The position peaked at $643K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • State of New Jersey Common Pension Fund D reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 29,827 Avadel Pharmaceuticals shares in Q1 2026, an estimated $643K.
  • State of New Jersey Common Pension Fund D first reported a position in Avadel Pharmaceuticals in Q4 2015 and held it in 16 quarters.
  • State of New Jersey Common Pension Fund D's Avadel Pharmaceuticals position peaked at $643K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.